"As we collaborate on this journey, we have the opportunity to fund basic science research to find answers that will lead to prevention, clinical treatments, and an eventual cure for NMO Spectrum Disease."
Bill Guthy and Victoria Jackson, Founders
New Issue: The SPECTRUM Winter 2010 - Conference Edition
The Guthy-Jackson Charitable Foundation’s Volume 2 of The SPECTRUM is now available! This issue’s articles include:
- 2009 NMO Patient Session
- “Why NMO Matters”
- Letter from the Editor
- Vitamin D and NMO
- Map of NMO Clinicians in the U.S
- Photos from the Patient Session
- “A Daughter’s Cure is Priceless”
- Calendar of Events
- 2010 “To Do” List
- More
NEW ANTIBODY MARKER AIDS IN DIAGNOSIS OF NEUROMYELITIS OPTICA
A team of Mayo Clinic scientists led by Dr. Vanda Lennon recently reported the discovery of a protein targeted by an antibody that distinguishes neuromyelitis optica (NMO, also known as Devic's disease) from more common forms of multiple sclerosis (MS) that are generally less severe. (See publications below.) The antibody is proving to be a valuable blood test for establishing the diagnosis of NMO and related diseases in the early symptom stage. This distinction is important because optimal treatments differ for NMO and MS.